First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
Clinical trial NCT04535167 · COMPLETED
Trial details
- NCT number
- NCT04535167
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-06-07
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.